[1]
|
T. Frieden, T. Stering, S. Munsiff, C. Watt and C. Dye, “Tuberculosis,” The Lancet, Vol. 362, No. 7, 2003, pp. 887-889.
|
[2]
|
I. Smith and P. L. Lin, “Rodgers Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Mode,” Infection and Immunity, Vol. 12, No. 77, 2009, pp. 845-855.
|
[3]
|
K. H. Costenbader, L. B. Chibnik and P. H. Schur, “Discordance between Erythrocyte Sedimentation Rate and c-Reactive Protein Measurement: Clinical Significance,” Clinical and Experimental Rheumatology, Vol. 25, No. 5, 2007, pp. 746-749.
|
[4]
|
L. Holley, N. Woodland, W. T. Hung, et al., “Influence of Fibrinogen and Hematocrit on Erythrocyte Sedimentation Kinetics,” Biorheology, Vol. 36, 1999, pp. 287-297.
|
[5]
|
H. C. Sox and M. H. Liang, “The Erythrocyte Sedimentation Rate. Guidelines for Rational Use,” Annals of Internal Medicine, Vol. 104, No. 4, 1986, pp. 515-523.
doi:10.7326/0003-4819-104-4-515
|
[6]
|
W. S. Tillet and T. Francis, “Serological Reactions in Pneumonia with a Non Protein Somatic Fraction of Pneumococcus,” Journal of Experimental Medicine, Vol. 52, No. 4, 1930, pp. 561-571. doi:10.1084/jem.52.4.561
|
[7]
|
M. B. Pepys, J. G. Lanham and F. C. De Beer, “C-Reactive Protein in SLE,” Chin Rheum Dis, Vol. 8, 1982, pp. 91-103.
|
[8]
|
C. Gabay, P. Roux-Lombard, P. De Moer-Loose, et al., “Absence of Correlation between Interleukin 6 and C-Reactive Protein Blood Levels in Systemic Lupus Erythematosus Compared with Rheumatological Arthritis,” Journal of Rheumatology, Vol. 20, 1993, pp. 815-821.
|
[9]
|
L. M. Vila, G. S. Alarcon, G. J. McGin, et al., “Systemic Lupus Erythematosus Cohort (LUMINA): XXIX. Elevation of Erythrocyte Sedimentation Rate Is Associated with Disease Activity and Damage Accrual,” Journal of Rheumatology, Vol. 32, 2005, pp. 2150-2155.
|
[10]
|
C. N. Suh, H. Y. Chun, Y. M. Ye, et al., “Unresponsiveness of C-Reactive Protein in the Non Infectious Inflammation of Systemic Lupus Erythematosus Is Associated with Interleukin 6,” Clinical Immunology, Vol. 119, No. 3, 2006, pp. 291-296. doi:10.1016/j.clim.2005.11.006
|
[11]
|
D. A. Ojo, S. J. Jacob and C. I. Ayolabi, “C-Reactive Protein in Tuberculosis and Human Immunodeficiency Virus Infections in Abeokuta, Nigeria,” Bayero Journal of Pure and Applied Sciences, Vol. 4, No. 2, 2011, pp. 91-96.
|
[12]
|
J. Van der Broek, G. Arpacia and G. Gilberto, “Impact of Human Immunodeficiency Virus Infection on the Outcome of Treatment and Survival of Tuberculosis Patients in Mivariza, Tanzania,” International Journal of Tuberculosis, Vol. 2, No. 7, 2008, pp. 547-552.
|
[13]
|
E. J. Kanfer and B. A. Nicol, “Haemoglobin Concentration and Erythrocyte Sedimentation Rate in Primary Case Patients,” Journal of the Royal Society of Medicine, Vol. 120, No. 1, 1997, pp. 54-62.
|
[14]
|
T. Husain and D. Kim, “C-Reactive Protein and Erythrocyte Sedimentation Rate in Orthopaedics,” The University of Pennysylvannia Orthopaedic Journal, Vol. 15, 2002, pp. 13-16.
|
[15]
|
S. G. Deodhase, “C-Reactive Protein,” Clinical Applications.
http://www.embeediagnostics.com/features/crp.htm
|
[16]
|
F. Wolfe, “Comparative Usefulness of C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis,” Journal of Rheumatology, Vol. 24, 1997, pp. 1477-1485.
|
[17]
|
L. Xu and Y. Y. Gu, “The Significance of C-Reactive Protein I Systemic Lupus Erthematosils Activity and Infection,” Zhongua Fengshibing Xue Zahzhi, Vol. 4, No. 6, 2000, pp. 288-389.
|
[18]
|
D. L. Jaye and K. B. Waites, “Clinical Applications of C-Reactive Protein in Pediatrics,” Pediatric Infectious Disease Journal, Vol. 16, No. 8, 1997, pp. 735-747.
doi:10.1097/00006454-199708000-00003
|
[19]
|
X. N. Tian, “Clinic Diversity Analysis of ESR after Anti-Tuberculosis Treatment in Bone and Joint Tuberculosis,” Zhongguo Jiaxing Waike Zazhi, Vol. 10, No. 9, 2005, pp. 1512-1513.
|
[20]
|
Z. Kartaloglu, O. Okutan, E. Bozkanat, et al., “The Course of Adenosine Deaminase Levels in Patients with Pulmonary Tuberculosis,” Medical Science Monitor, Vol. 12, No. 11, 2006, pp. 476-480.
|
[21]
|
W. M. Jin and H. Y. Zhu, “The Clinical Value of CRP in Diagnosis Tuberculosis,” Linchuang Feike Zazhi, Vol. 13, No. 3, 2008, p. 306.
|
[22]
|
D. Wilson, J. Nachega, C. Morroni, et al., “Diagnosing Smear Negative Tuberculosis Using Case Definitions and Treatment Response in HIV Infected Adults,” International Journal of Tuberculosis and Lung Disease, Vol. 10, No. 1, 2006, pp. 31-38.
|